Charles River Laboratories | CRL - Interest Income


Charles River Laboratories reported $1.1 in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Agilent USD 17M 1000K Sep/2025
Align Technology USD 3.25M 390K Sep/2025
Bio-Rad Laboratories USD 13.7M 1000K Sep/2025
Bruker USD 4.4M 1.5M Sep/2025
Charles River Laboratories USD 1.1 1.1M Sep/2025
Concord Medical Services Hldg CNY 5.8M 659K Jun/2023
Danaher USD 1.27 8M Sep/2025
Dentsply International USD 4M 1000K Mar/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Hologic USD 0.79 18.9M Dec/2025
Illumina USD 0.98 10M Sep/2025
Incyte USD 30.75M 3.97M Dec/2025
Intrexon USD 319K 602K Jun/2024
IQVIA Holdings USD 13M 3M Sep/2025
Merck EUR 17M 11M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Quest Diagnostics USD 3M 1000K Sep/2025
Revvity USD 0.4 8.34M Sep/2025
Thermo Fisher Scientific USD 4.27 297M Sep/2025
United Therapeutics USD 46.4M 4.9M Sep/2025
Veradigm USD 1.7M 1.6M Sep/2022
Waters USD 2.5 4.51M Sep/2025
West Pharmaceutical Services USD 4.7M 1.1M Sep/2025